These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7655144)

  • 1. Zipeprol: primary dependence in an unaddicted patient.
    Mallaret MP; Lauby VL; Cornier PH; Barjhoux CE; Danel VC
    Ann Pharmacother; 1995 May; 29(5):540. PubMed ID: 7655144
    [No Abstract]   [Full Text] [Related]  

  • 2. Zipeprol is a newly abused antitussive with an opioid spectrum and hallucinogenic effects.
    Janiri L; Mannelli P; Persico AM; Diodato S; Tempesta E
    Drug Alcohol Depend; 1991 Mar; 27(2):121-5. PubMed ID: 2055160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuropsychic side-effects of therapeutic doses of zipeprol]].
    Lauby V; Imbert B; Eysseric H; Dufrêne I; Mallaret M
    Rev Med Interne; 1995; 16(3):212-3. PubMed ID: 7740233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Habituation to zipeprol hydrochloride during pregnancy.
    Slobodkin D; Thompson D; Levin G; Jesurun CA
    J Subst Abuse Treat; 1992; 9(2):129-31. PubMed ID: 1512801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Convulsions with 3 antitussive substituted derivatives of piperazine (zipeprol, eprazinone, eprozinol)].
    Merigot P; Garnier R; Efthymiou ML
    Ann Pediatr (Paris); 1985 Jun; 32(6):504-6, 511. PubMed ID: 4026148
    [No Abstract]   [Full Text] [Related]  

  • 6. Zipeprol: preclinical assessment of abuse potential.
    Acteo MD; Bowman E; Butelman E; Englis JA; Harrish L; Jacobson AE; Mattson MV; Medzihradsky F; Patrick G; Rowlett JK; Smith CB; Winger G; Woods JH; Woolverton WL
    Drug Alcohol Depend; 1996 Oct; 42(2):93-104. PubMed ID: 8889408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographic characteristics of zipeprol-associated deaths in Korea.
    Chung HS; Choi HK; Kim EM; Park MJ; Chung KH; Yoo YC
    Arch Pharm Res; 1998 Jun; 21(3):286-90. PubMed ID: 9875445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Addiction to zipeprol].
    Marembert A; Morin D
    Presse Med; 1993 Mar; 22(11):550. PubMed ID: 8511083
    [No Abstract]   [Full Text] [Related]  

  • 9. Postmortem distribution of zipeprol.
    Yoo Y; Chung H; Kim E; Kim M
    J Anal Toxicol; 1994; 18(4):213-6. PubMed ID: 7967542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cough mixture addiction--a case report.
    Tan CH; Kua EH; Lee EL
    Singapore Med J; 1988 Apr; 29(2):186-7. PubMed ID: 3399925
    [No Abstract]   [Full Text] [Related]  

  • 11. Lethal poisoning by zipeprol in drug addicts.
    Crippa O; Polettini A; Avato FM
    J Forensic Sci; 1990 Jul; 35(4):992-9. PubMed ID: 2391486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General pharmacological properties of a new non-opiate antitussive: zipeprol (3024 CERM). II. Actions on the cardiovascular system, intestinal transit and central nervous system.
    Cosnier D; Hache J; Labrid C; Rispat G
    Arzneimittelforschung; 1976; 26(5):848-55. PubMed ID: 989357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zipeprol (Zinolta) abuse among American adolescents in Korea: a discussion of the problem, clinical presentation, and treatment.
    Ritchie EC; Andress D; Yi S; Styles JR
    Mil Med; 1996 Jan; 161(1):11-2. PubMed ID: 11082743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convulsions and cerebral oedema associated with zipeprol abuse.
    Perraro F; Beorchia A
    Lancet; 1984 Jan; 1(8367):45-6. PubMed ID: 6140367
    [No Abstract]   [Full Text] [Related]  

  • 15. [The problem of the addictive capacity of zipeprol. Results of an experimental and clinical investigation].
    Moroni F; Mannaioni PF
    Recenti Prog Med; 1986; 77(7-8):333-8. PubMed ID: 3024271
    [No Abstract]   [Full Text] [Related]  

  • 16. Fatal zipeprol intoxication.
    Kintz P; Cirimele V; Tracqui A; Mangin P
    Int J Legal Med; 1995; 107(5):267-8. PubMed ID: 7632605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of 2 antitussive agents in pediatrics (butamirate citrate in drinkable solution and zipeprol syrup)].
    Lejeune J; Weibel MA
    Rev Med Suisse Romande; 1990 Feb; 110(2):181-5. PubMed ID: 2315598
    [No Abstract]   [Full Text] [Related]  

  • 18. Turning to anything, just to get that high. A cough syrup ingredient is a popular drug.
    Schultz S
    US News World Rep; 2000 Jun; 128(22):60. PubMed ID: 10977214
    [No Abstract]   [Full Text] [Related]  

  • 19. Cough mixture dependence and stroke: implications for pseudoephedrine regulation.
    Bharatula A; New PW
    Med J Aust; 2011 Apr; 194(8):427. PubMed ID: 21495951
    [No Abstract]   [Full Text] [Related]  

  • 20. General pharmacological properties of a new non-opiate antitussive: zipeprol (3024 CERM). I. Action on respiratory function and acute toxicity.
    Rispat G; Burgi H; Cosnier D; Duchêne-Marullaz P; Streichenberger G
    Arzneimittelforschung; 1976 Apr; 26(4):523-30. PubMed ID: 8057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.